COVID-19: President Vladimir Putin on Tuesday said India and China may start producing Russia’s Sputnik V vaccine against COVID-19, cited the RIA news agency. TASS reported that the creation of a vaccine research centre for BRICS countries – Brazil, Russia, India, China and South Africa. Russia’s Sputnik V vaccine is 92 per cent effective in terms of protecting people from COVID 19, according to the interim trial results, the country’s sovereign wealth fund said on Nov 11. Russia Sputnik-V COVID-19 vaccine will be available for domestic use in August. It […]
Coronavirus vaccine
COVID-19: President Vladimir Putin on Tuesday said India and China may start producing Russia’s Sputnik V vaccine against COVID-19, cited the RIA news agency.
TASS reported that the creation of a vaccine research centre for BRICS countries – Brazil, Russia, India, China and South Africa.
Russia’s Sputnik V vaccine is 92 per cent effective in terms of protecting people from COVID 19, according to the interim trial results, the country’s sovereign wealth fund said on Nov 11.
Russia Sputnik-V COVID-19 vaccine will be available for domestic use in August. It will happen only before it started on the large-scale trials.
The Indian government has a great significance of partnership from a special friend of this nation.
In September, Reddy’s and the Russian Direct Investment Fund (RDIF), sovereign wealth fund, entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India.
Also Read: J&K encounter: 3 soldiers killed in action, 3 terrorists shot dead
According to the partnership, it was agreed upon a consensus that RDIF shall be liable to supply 100 million doses of the vaccine to Dr Reddy’s upon regulatory approval in India.
The Russian government sought India’s help in manufacturing the Sputnik V vaccine It also conducted Phase-3 trials and bridged the studies in the country, a top official said on Tuesday.
Also Read: Attorney General refuses to give nod for contempt case against Jagan Reddy
For the uninitiators, Sputnik V is an adenovirus vector-based vaccine. It was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology. It happened along with the registration of the Russian Direct Investment Fund, which was being done on August 11.
